Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

Skin biopsy is crucial for diagnosing unknown baldness causes.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Botulinum toxin A effectively treated a man's facial cysts with no side effects and lasting results.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Hair loss treatment caused more hair loss in a man.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Hair loss in postmenopausal woman caused by ovarian issue.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

The term "Porokeratotic Adnexal Ostial Nevus" is suggested as a more appropriate name.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Androgenetic alopecia is a common hair thinning condition linked to genetics and hormones.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.